Skip to main content

and
  1. Article

    Open Access

    Point-of-care BCR::ABL1 transcript monitoring using capillary dried blood in chronic myeloid leukemia patients

    Olga Sala-Torra, Lan Beppu, Qian Wu, Emily Welch, Erwin Berthier in Leukemia (2024)

  2. Article

    Open Access

    Rapid initial decline in BCR-ABL1 is associated with superior responses to second-line nilotinib in patients with chronic-phase chronic myeloid leukemia

    We evaluated BCR-ABL1 kinetics in patients treated with nilotinib and analyzed whether a dynamic model of changes in BCR-ABL1 levels over time could be used to predict long-term responses.

    Andrew M Stein, Giovanni Martinelli, Timothy P Hughes, Martin C Müller in BMC Cancer (2013)